SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen. Wang Y, Wang L, Cao H, Liu C, et al. J Med Virol 2020 Jul 21. doi: 10.1002/jmv.26320.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Wang L, Cao H, Liu C, et al. SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen. J Med Virol 2020 Jul 21. doi: 10.1002/jmv.26320.
PMID: 32691875